Peritoneal dialysis-current status and future challenges

Nature Reviews Nephrology

Volumn 9, Issue 7, 2013, Pages 399-408

  Davies, Simon J ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALTERNATIVE MEDICINE; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; GLOMERULUS FILTRATION RATE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEMODIALYSIS; HOME DIALYSIS; HUMAN; HYPOALBUMINEMIA; NON COMMUNICABLE DISEASE; OBESITY; PATIENT AUTONOMY; PATIENT CARE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF CARE;

BIOMEDICAL RESEARCH; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS;

EID: 84879792907     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.100     Document Type: Review

References (117)

1. Jain, A. K., Blake, P., Cordy, P. & Garg, A. X. Global trends in rates of peritoneal dialysis. J. Am. Soc. Nephrol. 23, 533-544 (2012).
2. Wang, H. et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2071-2094 (2012).
3. Gapminder Foundation. Gapminder world. Gapminder for a fact based world [online], http://www.gapminder.org/data/documentation (2013).
4. Christensen, K., Doblhammer, G., Rau, R. & Vaupel, J. W. Ageing populations: the challenges ahead. Lancet 374, 1196-1208 (2009).
5. Murray, C. J. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223 (2012).
6. Meguid El Nahas, A. & Bello, A. K. Chronic kidney disease: the global challenge. Lancet 365, 331-340 (2005). (Pubitemid 40139112)
7. Williams, M. E., Sandeep, J. & Catic, A. Aging and ESRD demographics: consequences for the practice of dialysis. Semin. Dial. 25, 617-622 (2012).
8. The Renal Association. UK Renal Registry Reports. UK Renal Registry [online], http://www.renalreg.com/Reports/reports.html (2013).
9. Gersh, B. J., Sliwa, K., Mayosi, B. M. & Yusuf, S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur. Heart J. 31, 642-648 (2010).
10. Ekundayo, O. J. et al. Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure. Am. J. Cardiol. 103, 88-92 (2009).
11. Ritchie, C. et al. Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure. Int. J. Cardiol. 134, 330-335 (2009).
12. Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380, 37-43 (2012).
13. Formiga, F. et al. Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur. J. Intern. Med. 24, 40-44 (2013).
14. Schäfer, I. et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS ONE 5, e15941 (2010).
15. Davies, S. J., Phillips, L., Naish, P. F. & Russell, G. I. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol. Dial. Transplant. 17, 1085-1089 (2002).
16. van Manen, J. G. et al. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am. J. Kidney Dis. 40, 82-89 (2002). (Pubitemid 34701215)
17. Loeb, D. F., Ghushchyan, V., Huebschmann, A. G., Lobo, I. E. & Bayliss, E. A. Association of treatment modality for depression and burden of comorbid chronic illness in a nationally representative sample in the United States. Gen. Hosp. Psychiatry 34, 588-597 (2012).
18. Noël, P. H., Frueh, B. C., Larme, A. C. & Pugh, J. A. Collaborative care needs and preferences of primary care patients with multimorbidity. Health Expect. 8, 54-63 (2005). (Pubitemid 40347318)
19. Agborsangaya, C. B., Lau, D., Lahtinen, M., Cooke, T. & Johnson, J. A. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual. Life Res. 22, 791-799 (2013).
20. Stenvinkel, P., Heimbürger, O., Lindholm, B., Kaysen, G. A. & Bergström, J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant. 15, 953-960 (2000). (Pubitemid 30410364)
21. Cesari, M. et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am. J. Clin. Nutr. 83, 1142-1148 (2006). (Pubitemid 44713116)
22. Organisation for Economic Co-operation and Development. Health at a glance 2011: OECD indicators. OECD [online], http://www.oecd.org/health/health- systems/healthataglance2011.htm (2011).
23. Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M. & Strong, K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 1929-1938 (2007). (Pubitemid 350192633)
24. Shepperd, S., Wee, B. & Straus, S. E. Hospital at home: home-based end of life care. Cochrane Database of Systematic Reviews, Issue 7. Art. No.: CD009231. http://dx.doi.org/10.1002/14651858.CD009231.
25. Shepperd, S. et al. Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data. CMAJ 180, 175-182 (2009).
26. Stacey, D. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD001431. http://dx.doi.org/10.1002/14651858.CD001431.pub3.
27. James, R. Dialysis and the environment: comparing home and unit based haemodialysis. J. Ren. Care. 33, 119-123 (2007).
28. The Renal Association. UK Renal Registry 14th Annual Report. UK Renal Registry [online], http://www.renalreg.com/Reports/2011.html (2012).
29. Rubin, H. R. et al. Patient ratings of dialysis care with peritoneal vs haemodialysis. JAMA 291, 697-703 (2004). (Pubitemid 38543789)
30. Tong, A. et al. The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies. Am. J. Kidney Dis. http://dx.doi.org/10.1053/j.ajkd.2012.08.045.
31. Kutner, N. G., Zhang, R., Barnhart, H. & Collins, A. J. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol. Dial. Transplant. 20, 2159-2167 (2005). (Pubitemid 41510092)
32. National Institute for Health and Care Excellence. Clinical Guideline 125. Peritoneal dialysis in the treatment of stage 5 chronic kidney disease. National Institute for Health and Care Excellence [online], http://publications. nice.org.uk/peritoneal-dialysis-cg125 (2011).
33. Golper, T. A. et al. Home dialysis in the new USA bundled payment plan: implications and impact. Perit. Dial. Int. 31, 12-16 (2011).
34. Just, P. M. et al. Economic evaluations of dialysis treatment modalities. Health Policy 86, 163-180 (2008).
35. Dhanakijcharoen, P. et al. The "PD First" policy in Thailand: three-years experiences (2008-2011). J. Med. Assoc. Thai. 94 (Suppl. 4), S153-S161 (2011).
36. Duong, U. et al. Glycaemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin. J. Am. Soc. Nephrol. 6, 1041-1048 (2011).
37. Liao, C. T. et al. Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. Nephrol. Dial. Transplant. 26, 4047-4054 (2011).
38. Chen, K. H. et al. Impaired fasting glucose association with mortality in non-diabetic patients on maintenance peritoneal dialysis. Am. J. Med. Sci. 341, 312-317 (2011).
39. Selby, N. M., Fialova, J., Burton, J. O. & McIntyre, C. W. The haemodynamic and metabolic effects of hypertonic-glucose and aminoacidbased peritoneal dialysis fluids. Nephrol. Dial. Transplant. 22, 870-879 (2007). (Pubitemid 46351699)
40. Little, J. et al. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J. Am. Soc. Nephrol. 9, 1931-1939 (1998). (Pubitemid 28443491)
41. Jialin, W., Yi, Z. & Weijie, Y. Relationship between body mass index and mortality in haemodialysis patients: a meta-analysis. Nephron Clin. Pract. 121, c102-c111 (2012).
42. de Mutsert, R., Grootendorst, D. C., Boeschoten, E. W., Dekker, F. W. & Krediet, R. T. Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib. Nephrol. 163, 124-131 (2009).
43. Stack, A. G., Murthy, B. V. & Molony, D. A. Survival differences between peritoneal dialysis and haemodialysis among "large" ESRD patients in the United States. Kidney Int. 65, 2398-2408 (2004). (Pubitemid 38670026)
44. McDonald, S. P., Collins, J. F. & Johnson, D. W. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J. Am. Soc. Nephrol. 11, 2894-2901 (2003). (Pubitemid 37305652)
45. Vonesh, E. F., Snyder, J. J., Foley, R. N. & Collins, A. J. The differential impact of risk factors on mortality in haemodialysis and peritoneal dialysis. Kidney Int. 66, 2389-2401 (2004).
46. van de Luijtgaarden, M. W. et al. Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol. Dial. Transplant. 26, 2940-2947 (2011).
47. Germing, A. et al. High frequency of diastolic dysfunction in a population-based cohort of elderly women-but poor association with the symptom dyspnea. BMC Geriatr. 11, 71 (2011).
48. Oliver, M. J. et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol. Dial. Transplant. 8, 2737-2744 (2010).
49. Lambert, M. C., Lage, C. & Kirchgessner, J. Stay.safe. A new PVC free system in long-term CAPD treatment. EDTNA ERCA J. 25, 30-34 (1999). (Pubitemid 29454857)
50. Voges, M., Faict, D., Lechien, G. & Taminne, M. Stability of drug additives in peritoneal dialysis solutions in a new container. Perit. Dial. Int. 24, 590-595 (2004). (Pubitemid 39567274)
51. United States Renal Data System. 2009 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. United States Renal Data System [online], http://www.usrds.org/atlas09.aspx (2009).
52. Kramer, A. et al. ERA-EDTA Registry. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol. Dial. Transplant. 24, 557-566 (2009).
53. Mehrotra, R. et al. Similar outcomes with haemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch. Intern. Med. 171, 110-118 (2011).
54. Yeates, K. et al. Haemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol. Dial. Transplant. 27, 568-575 (2012).
55. Noordzij, M. & Jager, K. J. Survival comparisons between haemodialysis and peritoneal dialysis. Nephrol. Dial. Transplant. 27, 385-387 (2012).
56. Bloembergen, W. E., Port, F. K., Mauger, E. A. & Wolfe, R. A. A comparison of mortality between patients treated with haemodialysis and peritoneal dialysis. J. Am. Soc. Nephrol. 6, 177-183 (1995).
57. Weinhandl, E. D. et al. Propensity-matched mortality comparison of incident haemodialysis and peritoneal dialysis patients. J. Am. Soc. Nephrol. 21, 499-506 (2010).
58. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01413074?term=NCT01413074&rank=1 (2011).
59. Mehrotra, R., Chiu, Y. W., Kalantar-Zadeh, K. & Vonesh, E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int. 76, 97-107 (2009).
60. Perl, J. et al. Haemodialysis vascular access modifies the association between dialysis modality and survival. J. Am. Soc. Nephrol. 22, 1113-1121 (2011).
61. Jaar, B. G. et al. Comparing the risk for death with peritoneal dialysis and haemodialysis in a national cohort of patients with chronic kidney disease. Ann. Intern. Med. 143, 174-183 (2005).
62. McDonald, S. P., Marshall, M. R., Johnson, D. W. & Polkinghorne, K. R. Relationship between dialysis modality and mortality. J. Am. Soc. Nephrol. 20, 155-163 (2009).
63. Termorshuizen, F. et al. Haemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis-analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J. Am. Soc. Nephrol. 14, 2851-2860 (2003). (Pubitemid 37305648)
64. Lindholm, B. & Davies, S. J. Timing of dialysis initiation and dialysis modality. Nat. Rev. Nephrol. 7, 66-68 (2011).
65. Davies, S. J. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int. Suppl. 103, S76-S83 (2006). (Pubitemid 44684780)
66. Johnson, D. W. et al. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 25, 1973-1979 (2010).
67. Cho, J. H. et al. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol. Dial. Transplant. 25, 1964-1973 (2010).
68. Davies, S. J. Overfill or ultrafiltration? We need to be clear. Perit. Dial. Int. 26, 449-451 (2006). (Pubitemid 44339977)
69. Han, S. H., Ahn, S. V., Yun, J. Y., Tranaeus, A. & Han, D. S. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis. Nephrol. Dial. Transplant. 27, 2044-2050 (2012).
70. Qi, H., Xu, C., Yan, H. & Ma, J. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit. Dial. Int. 31, 179-188 (2011).
71. de Jager, D. J. et al. Cardiovascular and non-cardiovascular mortality among patients starting dialysis. JAMA 302, 1782-1789 (2009).
72. Jansen, M. A. et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 62, 1046-1053 (2002). (Pubitemid 35316736)
73. Burton, J. O., Jefferies, H. J., Selby, N. M. & McIntyre, C. W. Haemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin. J. Am. Soc. Nephrol. 4, 1925-1931 (2009).
74. Selby, N. M. & McIntyre, C. W. Peritoneal dialysis is not associated with myocardial stunning. Perit. Dial. Int. 31, 27-33 (2011).
75. Just, P. M. et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol. Dial. Transplant. 23, 2365-2373 (2008). (Pubitemid 351957587)
76. Vanholder, R. et al. Reimbursement of dialysis: a comparison of seven countries. J. Am. Soc. Nephrol. 23, 1291-1298 (2012).
77. United States Renal Data System. 2012 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. United States Renal Data System [online], http://www.usrds.org/atlas.aspx (2012).
78. Castledine, C., Gilg, J., Rogers, C., Ben-Shlomo, Y. & Caskey, F. UK Renal Registry 13th Annual Report (December 2010): Chapter 15: UK renal centre survey results 2010: RRT incidence and use of home dialysis modalities. Nephron. Clin. Pract. 119 (Suppl. 2), c255-c267 (2011).
79. Castledine, C., Gilg, J., Rogers, C., Ben-Shlomo, Y. & Caskey, F. Factors affecting the number of patients treated with either peritoneal or home haemodialysis in the UK [abstract P219]. The Renal Conference 2012 [online], http://www.renal.org/Libraries/Abstracts/Renal-Association-Conference-2012- Abstract-Book.sflb.ashx (2012).
80. Oliver, M. J. & Quinn, R. R. Is the decline of peritoneal dialysis in the elderly a breakdown in the process of care? Perit. Dial. Int. 28, 452-456 (2008).
81. Oliver, M. J. et al. Home care assistance and the utilization of peritoneal dialysis. Kidney Int. 71, 2673-2678 (2007).
82. [No authors listed] Abstracts of the 14th Congress of the International Society of Peritoneal Dialysis. Kuala Lumpur, Malaysia. Perit. Dial. Int. 32 (Suppl. 3), S89-S188 (2012).
83. Oliver, M. J. et al. Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol. Dial. Transplant. 27, 810-816 (2012).
84. Povlsen, J. V. & Ivarsen, P. Assisted peritoneal dialysis: also for the late referred elderly patient. Perit. Dial. Int. 28, 461-467 (2008).
85. Lobbedez, T. et al. Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience. Nephrol. Dial. Transplant. 23, 290-294 (2008).
86. Brown, E. A., Dratwa, M. & Povlsen, J. V. Assisted peritoneal dialysis-an evolving dialysis modality. Nephrol. Dial. Transplant. 22, 3091-3092 (2007). (Pubitemid 350093458)
87. Castrale, C. et al. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrol. Dial. Transplant. 25, 255-262 (2010).
88. Lobbedez, T., Verger, C., Ryckelynck, J. P., Fabre, E. & Evans, D. Is assisted peritoneal dialysis associated with technique survival when competing events are considered? Clin. J. Am. Soc. Nephrol. 7, 612-618 (2012).
89. Brown, E. A. et al. Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol. Dial. Transplant. 25, 755-763 (2010).
90. Piraino, B. et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit. Dial. Int. 31, 614-630 (2011).
91. Li, P. K. et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit. Dial. Int. 30, 393-423 (2010).
92. Brown, M. C., Simpson, K., Kerssens, J. J., Mactier R. A. & Scottish Renal Registry. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit. Dial. Int. 31, 639-650 (2011).
93. Burke, M. et al. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicentre registry study. Am. J. Kidney Dis. 58, 429-436 (2011).
94. Fahim, M. et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am. J. Kidney Dis. 55, 690-697 (2010).
95. Jose, M. D. et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) 16, 19-29 (2011).
96. Martin, L. C. et al. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis Study (BRAZPD) patients. Clin. J. Am. Soc. Nephrol. 6, 1944-1951 (2011).
97. Davey, M. S. et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial T cell responses in early infection. PLoS Pathog. 7, e1002040 (2011).
98. García-López, E., Lindholm, B. & Davies, S. An update on peritoneal dialysis solutions. Nat.Rev. Nephrol. 8, 224-233 (2012).
99. Johnson, D. W. et al. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol. Dial. Transplant. 27, 4445-4453 (2012).
100. Johnson, D. W. et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J. Am. Soc. Nephrol. 23, 1097-1107 (2012).
101. Davies, S. J. What has balANZ taught us about balancing ultrafiltration with membrane preservation? Nephrol. Dial. Transplant. http://dx.doi.org/10. 1093/ndt/gfs594.
102. Davies, S. J., Mushahar, L., Yu, Z. & Lambie, M. Determinants of peritoneal membrane function over time. Semin. Nephrol. 31, 172-182 (2011).
103. Pletinck, A., Vanholder, R., Veys, N. & Van Biesen, W. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat. Rev. Nephrol. 8, 542-550 (2012).
104. Lambie, M., John, B., Mushahar, L., Huckvale, C. & Davies, S. J. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int. 78, 611-618 (2010).
105. [No authors listed] NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation. Am. J. Kidney Dis. 30 (Suppl. 2) S67-S136 (1997).
106. Davies, S. J., Phillips, L., Griffiths, A. M., Naish, P. F. & Russell, G. I. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int. 57, 1743-1754 (2000). (Pubitemid 30207934)
107. Gama-Axelsson, T. et al. Serum albumin as predictor of nutritional status in patients with ESRD. Clin. J. Am. Soc. Nephrol. 7, 1446-1453 (2012).
108. Mehrotra, R. et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with haemodialysis. Am. J. Kidney Dis. 58, 418-428 (2011).
109. Rao, R. et al. Effect of change in renal replacement therapy modality on laboratory variables: a cohort study from the UK Renal Registry. Nephrol. Dial. Transplant. 24, 2877-2882 (2009).
110. Van Biesen, W. et al. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS ONE 6, e17148 (2011).
111. John, B. et al. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 5, 1463-1470 (2010).
112. Paniagua, R. et al. NTproBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol. Dial. Transplant. 25, 551-557 (2010).
113. Tan, B. K., Chan, C. & Davies, S. J. Achieving euvolemia in peritoneal dialysis patients: a surprisingly difficult proposition. Semin. Dial. 23, 456-461 (2010).
114. Movilli, E. et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol. Dial. Transplant. 22 3547-3552 (2007). (Pubitemid 350212498)
115. Arbor Research Collaborative for Health. Peritoneal Dialysis Outcomes and Practice Patterns Study: Dialysis Outcomes and Practice Patterns Study expands to study peritoneal dialysis. Arborresearch.org [online] http://www. arborresearch.org/AboutUs/ArborResearchNewsPress/PDOPPSPeritonealDialysis.aspx (2013).
116. Winterbottom, A., Bekker, H. L., Conner, M. & Mooney, A. Choosing dialysis modality: decision making in a chronic illness context. Health Expect. http://dx.doi.org/10.1111/j.1369-7625.2012.00798.x.
117. European Training & Research in Peritoneal Dialysis. Project EuTRiPD. EuTRiPD [online], http://www.eutripd.eu/(2012).